AIM ImmunoTech Historical PE Ratio image   This AIM PE ratio history page last updated 5/10/2024
AIM ImmunoTech Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
4/2/2024
0.45-0.26-1.04NA
Q3 2023
11/14/2023
0.45-0.16-0.64NA
Q2 2023
8/15/2023
0.64-0.10-0.40NA
Q1 2023
5/15/2023
0.43-0.08-0.32NA
Q4 2022
4/3/2023
0.42-0.09-0.36NA
Q3 2022
11/15/2022
0.50-0.13-0.52NA
Q2 2022
8/15/2022
0.79-0.10-0.40NA
Q1 2022
5/13/2022
0.99-0.08-0.32NA
Q4 2021
3/31/2022
1.06-0.12-0.48NA
Q3 2021
11/16/2021
1.64-0.08-0.32NA
Q2 2021
8/16/2021
2.00-0.12-0.48NA
Q1 2021
5/18/2021
2.08-0.08-0.32NA
Q4 2020
3/31/2021
2.27-0.09-0.36NA
Q3 2020
11/13/2020
2.03-0.08-0.32NA
Q2 2020
8/17/2020
2.53-0.11-0.44NA
Q1 2020
5/14/2020
2.94-0.22-0.88NA
Q4 2019
3/31/2020
2.56-0.33-1.32NA
Q3 2019
11/14/2019
0.47-1.13-4.52NA
Q2 2019
8/15/2019
1.90-0.36-1.44NA
Q1 2019
5/16/2019
0.15-0.07-0.28NA
Q4 2018
4/1/2019
0.16-0.03-0.12NA
Q3 2018
11/15/2018
0.20-0.07-0.28NA
Q2 2018
8/15/2018
0.29-0.05-0.20NA
Q1 2018
5/16/2018
0.30-0.07-0.28NA
Q4 2017
4/2/2018
0.47-0.06-0.24NA
Q3 2017
11/14/2017
0.32-0.04-0.16NA
Q2 2017
8/14/2017
0.44-0.08-0.32NA
Q1 2017
5/15/2017
0.64-0.11-0.44NA
Q4 2016
3/31/2017
0.55-0.04-0.16NA
Q3 2016
11/14/2016
0.90-0.13-0.52NA
Q2 2016
8/15/2016
0.17-0.01-0.04NA
Q1 2016
5/16/2016
0.11-0.01-0.04NA
Q4 2015
3/29/2016
0.13-0.01-0.04NA
Q3 2015
11/16/2015
0.15-0.02-0.08NA
Q2 2015
8/13/2015
0.18-0.04-0.16NA
Q1 2015
5/13/2015
0.26-0.02-0.08NA
FY 2014
3/20/2015
0.23-0.09-0.36NA
Q3 2014
11/10/2014
0.29-0.02-0.08NA
Q2 2014
8/11/2014
0.28-0.03-0.12NA
Q1 2014
5/9/2014
0.31-0.02-0.08NA
FY 2013
3/14/2014
0.39-0.10-0.40NA
Q3 2013
11/8/2013
0.21-0.03-0.12NA
Q2 2013
8/9/2013
0.24-0.03-0.12NA
Q1 2013
5/8/2013
0.22-0.02-0.08NA
Q4 2012
3/18/2013
0.21-0.03-0.12NA
Q3 2012
11/2/2012
0.75-0.05-0.20NA
AIM ImmunoTech PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
4/2/2024
0.45-0.26-0.60NA
Q3 2023
11/14/2023
0.45-0.16-0.43NA
Q2 2023
8/15/2023
0.64-0.10-0.40NA
Q1 2023
5/15/2023
0.43-0.08-0.40NA
Q4 2022
4/3/2023
0.42-0.09-0.40NA
Q3 2022
11/15/2022
0.50-0.13-0.43NA
Q2 2022
8/15/2022
0.79-0.10-0.38NA
Q1 2022
5/13/2022
0.99-0.08-0.40NA
Q4 2021
3/31/2022
1.06-0.12-0.40NA
Q3 2021
11/16/2021
1.64-0.08-0.37NA
Q2 2021
8/16/2021
2.00-0.12-0.37NA
Q1 2021
5/18/2021
2.08-0.08-0.36NA
Q4 2020
3/31/2021
2.27-0.09-0.50NA
Q3 2020
11/13/2020
2.03-0.08-0.74NA
Q2 2020
8/17/2020
2.53-0.11-1.79NA
Q1 2020
5/14/2020
2.94-0.22-2.04NA
Q4 2019
3/31/2020
2.56-0.33-1.89NA
Q3 2019
11/14/2019
0.47-1.13-1.59NA
Q2 2019
8/15/2019
1.90-0.36-0.53NA
Q1 2019
5/16/2019
0.15-0.07-0.22NA
Q4 2018
4/1/2019
0.16-0.03-0.22NA
Q3 2018
11/15/2018
0.20-0.07-0.25NA
Q2 2018
8/15/2018
0.29-0.05-0.22NA
Q1 2018
5/16/2018
0.30-0.07-0.25NA
Q4 2017
4/2/2018
0.47-0.06-0.29NA
Q3 2017
11/14/2017
0.32-0.04-0.27NA
Q2 2017
8/14/2017
0.44-0.08-0.36NA
Q1 2017
5/15/2017
0.64-0.11-0.29NA
Q4 2016
3/31/2017
0.55-0.04-0.19NA
Q3 2016
11/14/2016
0.90-0.13-0.16NA
Q2 2016
8/15/2016
0.17-0.01-0.05NA
Q1 2016
5/16/2016
0.11-0.01-0.08NA
Q4 2015
3/29/2016
0.13-0.01-0.09NA
Q3 2015
11/16/2015
0.15-0.02-0.17NA
Q2 2015
8/13/2015
0.18-0.04-0.17NA
Q1 2015
5/13/2015
0.26-0.02-0.16NA
FY 2014
3/20/2015
0.23-0.09-0.16NA
Q3 2014
11/10/2014
0.29-0.02-0.17NA
Q2 2014
8/11/2014
0.28-0.03-0.18NA
Q1 2014
5/9/2014
0.31-0.02-0.18NA
FY 2013
3/14/2014
0.39-0.10-0.18NA
Q3 2013
11/8/2013
0.21-0.03-0.11NA
Q2 2013
8/9/2013
0.24-0.03-0.13NA
Q1 2013
5/8/2013
0.22-0.02NANA
Q4 2012
3/18/2013
0.21-0.03NANA
Q3 2012
11/2/2012
0.75-0.05NANA
How should the AIM historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like AIM ImmunoTech. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this AIM Historical PE Ratio page.

What is the average historical PE for AIM based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The AIM historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for AIM based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The AIM historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the AIM ImmunoTech Historical PE Ratio information for AIM ImmunoTech' stock. The average AIM historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average AIM historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this AIM historical PE result, against the recent PE: when this page was posted on 5/9/2024, the most recent closing price for AIM had been 0.44, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on AIM or any other given stock, valuation analysis for AIM can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate AIM ImmunoTech PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for AIM. Thanks for visiting, and the next time you need to research AIM Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding VII, PTCT Stock Predictions, Institutional Holders of SSYS.

 

AIM ImmunoTech Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.